Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: A cross-sectional national survey

Fundamental and Clinical Pharmacology

Volumn 21, Issue 4, 2007, Pages 371-378

  Diatta, Thierno ^a,c,d   Blazejewski, Sylvie ^a   Portier, Arnaud ^b   Lignot, Séverine ^a   Quesnot, Ariane ^b   Moore, Nicholas ^a   Fourrier Réglat, Annie ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM U657   (France)

^c CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^d Lilly France   (France)

Author keywords

Antipsychotic; Cross sectional study; Outpatients; Pharmacoepidemiology; Schizophrenia

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; CYAMEMAZINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PERICIAZINE; PERPHENAZINE; PHENOTHIAZINE; PIPOTIAZINE; RISPERIDONE; SULTOPRIDE; THIOPROPERAZINE; THIORIDAZINE; THIOXANTHENE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CONFIDENCE INTERVAL; DISEASE DURATION; DRUG MECHANISM; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; MENTAL PATIENT; MOOD DISORDER; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SCHIZOPHRENIA; VOLUNTEER;

ADOLESCENT; ADULT; AGE FACTORS; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; COMMUNITY MENTAL HEALTH CENTERS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SCHIZOPHRENIA;

EID: 34447502546     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00492.x     Document Type: Article

References (18)

1. Jablensky A. Schizophrenia: epidemiology. Curr Opin Psychiatry (1999) 12 19 28.
2. Meltzer H., Gill B., Petticrew M. The prevalence of psychiatric morbidity among adults living in private households. HMSO, London, 1995.
3. Bagnall A.M., Jones L., Ginnelly L. et al. A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technol Assess (2003) 7 1 193.
4. Sarfati Y., Olivier V., Bouhassira M. [New antipsychotics in the treatment of schizophrenia. A European survey]. Encephale (1999) 25 658 666.
5. Leucht S., Barnes T.R., Kissling W., Engel R.R., Correll C., Kane J.M. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry (2003) 160 1209 1222.
6. Davis J.M., Chen N., Glick I.D. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry (2003) 60 553 564.
7. National Institute for Clinical Excellence (NICE). Guidance on the use of newer (atypical) antipsychotic agents for the treatment of schizophrenia. NICE, London, 2002.
8. Fédération Française de Psychiatrie. Conférence de consensus: schizophrénie debutante: diagnostic et modalités thérapeutiques, 2003. http://psydoc-fr.broca.inserm.fr/ conf&rm/conf/confschizo2/prschizo.html.
9. Bret P., Bonnet F., Bret M.C., Jaffre A. Use of atypical antipsychotics in Charles Perrens psychiatric hospital Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone. Encephale (2002) 28 329 342.
10. Brunot A., Lachaux B., Sontag H. et al. Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: patient characteristics, antipsychotic treatment, and care management for schizophrenia. Encephale (2002) 28 129 138.
11. Ashcroft D.M., Frischer M., Lockett J., Chapman S.R. Variations in prescribing atypical antipsychotic drugs in primary care: cross-sectional study. Pharmacoepidemiol Drug Saf (2002) 11 285 289.
12. Lukasiewicz M., Gasquet I., Casadebaig F. et al. Predictive factors of the number and the dose of anti-psychotics in a cohort of schizophrenic patients. Pharmacoepidemiol Drug Saf (2006) 15 594 601.
13. Tapp A., Wood A.E., Secrest L., Erdmann J., Cubberley L., Kilzieh N. Combination antipsychotic therapy in clinical practice. Psychiatr Serv (2003) 54 55 59.
14. Tempier R.P., Pawliuk N.H. Conventional, atypical, and combination antipsychotic prescriptions: a 2-year comparison. J Clin Psychiatry (2003) 64 673 679.
15. Fourrier A., Gasquet I., Allicar M.P., Bouhassira M., Lepine J.P., Begaud B. Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists. Br J Clin Pharmacol (2000) 49 80 86.
16. Agence Nationale d'Acréditation et d'Evaluation en Santé (ANAES). La prescription des neuroleptiques. Prescriptions et références médicales, ISBN 2-910653-11-0, 1995.
17. Acquaviva E., Gasquet I., Falissard B. Psychotropic combination in schizophrenia. Eur J Clin Pharmacol (2005) 61 855 861.
18. Montout C., Casadebaig F., Lagnaoui R. et al. Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients. Schizophr Res (2002) 57 147 156.